Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality
worldwide and its incidence continues to rise. While cirrhosis underlies most cases of HCC …

Hepatocellular carcinoma recurs in 70–80% of cases following potentially curative resection
or ablation and the immune component of the liver microenvironment plays a key role in …

Background No adjuvant treatment has been established for patients who remain at high
risk for hepatocellular carcinoma recurrence after curative-intent resection or ablation. We …

Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the
fourth most common malignancy and the second leading cause of tumor-related death …

Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in
China, is the fourth most common malignancy and the second leading cause of tumor …

Abstract Background: Hepatocellular carcinoma (HCC)(about 85–90% of primary liver
cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis …

Standard for diagnosis and treatment of primary liver cancer (2022 edition) 中文|English ISSN
1001-5256 (Print) ISSN 2097-3497 (Online) CN 22-1108/R Home About Journal 1.Journal …

Objective: To review the current management, outline recent advances and address
controversies in the management of hepatocellular carcinoma (HCC). Summary of …

Hepatocellular carcinoma (HCC) is one of the most common malignancies, with an
increasing incidence. With advances in surgical techniques and instrumentation and the …

BACKGROUND & AIMS: The aim of this study was to compare liver resection and
radiofrequency ablation in patients with single hepatocellular carcinoma⩽ 3cm and …